Bednar KJ - Search Results

1

Exploiting CD22 To Selectively Tolerize Autoantibody Producing B-Cells in Rheumatoid Arthritis.

Bednar KJ, Nycholat CM, Rao TS, Paulson JC, Fung-Leung WP, Macauley MS. Bednar KJ, et al. ACS Chem Biol. 2019 Apr 19;14(4):644-654. doi: 10.1021/acschembio.8b01018. Epub 2019 Mar 20. ACS Chem Biol. 2019. PMID: 30835424 Free PMC article.

2

Human CD22 Inhibits Murine B Cell Receptor Activation in a Human CD22 Transgenic Mouse Model.

Bednar KJ, Shanina E, Ballet R, Connors EP, Duan S, Juan J, Arlian BM, Kulis MD, Butcher EC, Fung-Leung WP, Rao TS, Paulson JC, Macauley MS. Bednar KJ, et al. J Immunol. 2017 Nov 1;199(9):3116-3128. doi: 10.4049/jimmunol.1700898. Epub 2017 Sep 29. J Immunol. 2017. PMID: 28972089 Free PMC article.

3

Antigenic Liposomes for Generation of Disease-specific Antibodies.

Bednar KJ, Hardy L, Smeekens J, Raghuwanshi D, Duan S, Kulis MD, Macauley MS. Bednar KJ, et al. J Vis Exp. 2018 Oct 25;(140):58285. doi: 10.3791/58285. J Vis Exp. 2018. PMID: 30417864 Free PMC article.

4

CD137 Plays Both Pathogenic and Protective Roles in Type 1 Diabetes Development in NOD Mice.

Forsberg MH, Ciecko AE, Bednar KJ, Itoh A, Kachapati K, Ridgway WM, Chen YG. Forsberg MH, et al. Among authors: bednar kj. J Immunol. 2017 May 15;198(10):3857-3868. doi: 10.4049/jimmunol.1601851. Epub 2017 Mar 31. J Immunol. 2017. PMID: 28363905 Free PMC article.

5

Enoxacin Up-Regulates MicroRNA Biogenesis and Down-Regulates Cytotoxic CD8 T-Cell Function in Autoimmune Cholangitis.

Itoh A, Adams D, Huang W, Wu Y, Kachapati K, Bednar KJ, Leung PSC, Zhang W, Flavell RA, Gershwin ME, Ridgway WM. Itoh A, et al. Among authors: bednar kj. Hepatology. 2021 Aug;74(2):835-846. doi: 10.1002/hep.31724. Epub 2021 Aug 10. Hepatology. 2021. PMID: 33462854

6

Soluble CD137 Ameliorates Acute Type 1 Diabetes by Inducing T Cell Anergy.

Itoh A, Ortiz L, Kachapati K, Wu Y, Adams D, Bednar K, Mukherjee S, Chougnet C, Mittler RS, Chen YG, Dolan L, Ridgway WM. Itoh A, et al. Front Immunol. 2019 Nov 7;10:2566. doi: 10.3389/fimmu.2019.02566. eCollection 2019. Front Immunol. 2019. PMID: 31787971 Free PMC article.

7

Recombinant soluble CD137 prevents type one diabetes in nonobese diabetic mice.

Kachapati K, Bednar KJ, Adams DE, Wu Y, Mittler RS, Jordan MB, Hinerman JM, Herr AB, Ridgway WM. Kachapati K, et al. Among authors: bednar kj. J Autoimmun. 2013 Dec;47:94-103. doi: 10.1016/j.jaut.2013.09.002. Epub 2013 Oct 18. J Autoimmun. 2013. PMID: 24145149

8

The non-obese diabetic (NOD) mouse as a model of human type 1 diabetes.

Kachapati K, Adams D, Bednar K, Ridgway WM. Kachapati K, et al. Methods Mol Biol. 2012;933:3-16. doi: 10.1007/978-1-62703-068-7_1. Methods Mol Biol. 2012. PMID: 22893397

9

Targeting innate immunity for treatment of type 1 diabetes.

Bednar KJ, Ridgway WM. Bednar KJ, et al. Immunotherapy. 2014;6(12):1239-42. doi: 10.2217/imt.14.96. Immunotherapy. 2014. PMID: 25524380 No abstract available.

10

Reversal of New-Onset Type 1 Diabetes With an Agonistic TLR4/MD-2 Monoclonal Antibody.

Bednar KJ, Tsukamoto H, Kachapati K, Ohta S, Wu Y, Katz JD, Ascherman DP, Ridgway WM. Bednar KJ, et al. Diabetes. 2015 Oct;64(10):3614-26. doi: 10.2337/db14-1868. Epub 2015 Jun 30. Diabetes. 2015. PMID: 26130764 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters